Home Markets Q32 Bio: Oppenheimer slashes price target on mixed trial results

Q32 Bio: Oppenheimer slashes price target on mixed trial results

Dec 11, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target–on-mixed-trial-results-3765273

You May Also Like

Hellman’s mayonnaise maker Unilever in takeover talks with McCormick for food business

European stocks open higher as U.S. moves to reassure markets

Europe shares set for third straight weekly loss as Mideast war grinds on

FCC approves $3.5 billion sale of Tegna to Nexstar despite state objections

Alibaba HK shares slide as dismal Q3 earnings overshadow AI, cloud growth

US says it disrupted botnets that infected over 3 million devices worldwide